Compounded semaglutide, tirzepatide and liraglutide could be harder to come by starting this summer, if the U.S. Food and ...
In Canada, health regulators took one step to fill that gap by approving a generic version of semaglutide, which is the ...
On April 30, 2026, the U.S. Food and Drug Administration announced that it is proposing to exclude semaglutide, tirzepatide, and liraglutide from ...
Semaglutide treats type 2 diabetes and can support weight loss with diet and exercise. It works by mimicking glucagon-like peptide-1 (GLP-1) to boost insulin and reduce appetite. Compounded ...
People who order low-cost versions of the wildly popular weight-loss drugs Wegovy and Zepbound from so-called compounding pharmacies might soon see disruptions in their medication. The U.S. Food and ...
Pharmacists and doctors can make compounded medications by combining, mixing, or altering various ingredients to meet a specific need. But because these medications don’t have Food and Drug ...
The US Food and Drug Administration (FDA) is proposing the creation of two lists of drugs or drug categories that are difficult to compound under sections 503A and 503B of the Federal Food, Drug, and ...
The proposal could affect telehealth services that rely on outside facilities to produce the knockoff drugs in bulk.
When you have to go on a medication, your doctor will probably prescribe a premade one that's FDA-approved. But sometimes, they may want you to go on a compounded medicine that's specifically made for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results